Vesicle Therapeutics
PrivateLast Round
Grant
May 21, 2026
Total Funding Raised
$2.57M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Vesicle Therapeutics operates in Healthcare & Life Sciences and is based in Niwot, Colorado. Its latest recorded funding round was a Grant round in May 2026.
Vesicle Therapeutics is a biotechnology company that develops programmable extracellular vesicles, known as gectosomes, to deliver macromolecular therapeutics to intracellular targets.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vesicle Therapeutics Comparables
Compare Vesicle Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eascra Biotech | 87% | |
| SHIFTBIO | 82% | |
| Carus Bio | 82% |
For institutional investors. Book with your work email.
Vesicle Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 21, 2026 | ||||
| Grant | Sep 16, 2025 | ||||
| Grant | Oct 28, 2024 | ||||
| Grant | May 19, 2022 | ||||
| Grant | May 1, 2022 | ||||
Seed | Apr 5, 2022 |
For institutional investors. Book with your work email.
Vesicle Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Venture Partners at CU Boulder | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 21, 2026
$250K grant round completed.
- Sep 16, 2025
$400K grant round completed.
For institutional investors. Book with your work email.
Vesicle Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vesicle Therapeutics's valuation, stock price, and market status.
Is Vesicle Therapeutics a public or private company?
Vesicle Therapeutics is a private company.
What is the current stock price of Vesicle Therapeutics?
Vesicle Therapeutics is a private company, so its shares have no public market price. Caplight tracks Vesicle Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vesicle Therapeutics worth (valuation)?
Valuation information for Vesicle Therapeutics is not publicly available.
Can I buy Vesicle Therapeutics stock?
Vesicle Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vesicle Therapeutics's last funding round?
Vesicle Therapeutics's most recent funding round was Grant on May 21, 2026.
Who are the main investors in Vesicle Therapeutics?
Key investors in Vesicle Therapeutics include Venture Partners at CU Boulder.
Will Vesicle Therapeutics IPO soon?
No public IPO plans have been announced for Vesicle Therapeutics.
How can I track Vesicle Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Vesicle Therapeutics's shares on secondary markets.